New safety information about Evra (norelgestromin and ethinyl estradiol) Transdermal System
- For Health Professionals
- For the Public
- Janssen-Ortho Inc.
Date: 2006-11-23
Reports of Bowel Obstruction and Gastrointestinal Perforation with Rituxan (rituximab)
- For Health Professionals
- For the Public
- Hoffmann - La Roche Limited
Date: 2006-11-14
Association of Avastin (bevacizumab) with hypertensive encephalopathy and reversible posterior leukoencephalopathy syndrome (RPLS)
- For Health Professionals
- For the Public
- Hoffmann - La Roche Limited
Date: 2006-10-27
Association of CellCept (mycophenolate mofetil) and sirolimus containing immunosuppressant regimen with higher rate of acute rejection in cardiac transplant patients switched from calcineurin inhibitors
- For Health Professionals
- For the Public
- Hoffmann-La Roche Limited
Date: 2006-10-25
Updated Safety Information on Ketek (telithromycin) and hepatic events, aggravation of myasthenia gravis and syncope
- For Health Professionals
- For the Public
- sanofi-aventis Canada Inc.
Date: 2006-10-03
Important Safety Information on Gleevec (imatinib mesylate)
- For Health Professionals
- For the Public
- Novartis Pharmaceuticals Canada Inc.
Date: 2006-10-02
Association of a Rapamune (sirolimus) containing immunosuppressant regimen with a high rate of acute rejection in de novo renal transplant patients
- For Health Professionals
- For the Public
- Wyeth Pharmaceuticals
Date: 2006-08-24
Association of Lamictal (lamotrigine) with an increased risk of non-syndromic oral clefts
- For Health Professionals
- For the Public
- GlaxoSmithKline Inc.
Date: 2006-08-08
Recall of D-TRONplus Insulin Pump Power Packs
- For the Public
- Disetronic Medical Systems, Inc.
Date: 2006-07-28
Possible Association of Remicade (infliximab) with hepatosplenic T-cell lymphoma in pediatric and young adult patients with Crohn's disease
- For Health Professionals
- For the Public
- Schering Canada Inc.
Date: 2006-07-27
Important Safety Information Regarding Intracranial Hemorrhage in Patients Receiving Aptivus (tipranavir) Capsules
- For the Public
- For Health Professionals (2006-07-05)
- Boehringer Ingelheim (Canada) Ltd
Date: 2006-07-14
Association of the erectile dysfunction medications Cialis (tadalafil), Levitra (vardenafil hydrochloride) and Viagra (sildenafil citrate) with visual problems
- For Health Professionals
- For the Public
- Eli Lilly Canada Inc.
- Bayer Inc.
- Pfizer Canada Inc.
Date: 2006-06-28
Important Safety and Efficacy Information on Iressa (gefitinib) 250 mg Tablets
- For Health Professionals
- For the Public
- AstraZeneca Canada Inc.
Date: 2006-06-05
Update regarding the association of Tequin (gatifloxacin) with serious hypoglycemia and hyperglycemia
- For Health Professionals
- For the Public
- Bristol-Myers Squibb Canada
Date: 2006-05-17
Important safety information concerning certain ACCU-CHEK Aviva glucose monitors.
- For Health Professionals
- For the Public
- Roche Diagnostics
Date: 2006-02-01
Association of WinRho SDF [Rho(D) Immune Globulin (Human)] with Intravascular Hemolysis in the treatment of Immune Thrombocytopenic Purpura
- Notice to Hospitals
- For the Public
- Cangene Corporation
Date: 2006-01-26
Association of Macugen (pegaptanib sodium injection) with hypersensitivity reactions
- For Health Professionals
- For the Public
- Pfizer Canada Inc.
Date: 2006-01-23
Important Safety Information on anti-TNFα Therapy: ENBREL (etanercept), HUMIRA (adalimumab), and REMICADE (infliximab)
- For Health Professionals
- For the Public
- Amgen Canada, Inc., Abbott Laboratories, Ltd., and Schering Canada, Inc.
Date: 2006-01-18